Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.
Rachel Souza DawsonKristen A FeemsterE David G McIntoshUlrike K BuchwaldPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)